UK markets open in 6 hours 40 minutes

Adamis Pharmaceuticals Corp (CY3.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.90000.0000 (0.00%)
At close: 08:36AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,446
4,756
2,209
2,777
22,114
Cost of revenue
5,370
6,187
6,872
6,327
15,479
Gross profit
-3,924
-1,431
-4,663
-3,550
6,635
Operating expenses
Research development
11,716
10,380
11,262
8,040
10,376
Selling general and administrative
12,993
13,248
16,144
20,090
25,288
Total operating expenses
24,709
23,628
27,406
28,129
35,664
Operating income or loss
-28,634
-25,059
-32,069
-31,680
-29,029
Interest expense
379.392
-
6.649
4.921
123.258
Total other income/expenses net
-1,590
-1,183
-2,523
-4,159
1,648
Income before tax
-30,608
-26,197
-34,600
-35,844
-27,504
Income tax expense
0.796
2
0.796
2.4
8.672
Income from continuing operations
-30,609
-26,199
-34,600
-35,846
-27,513
Net income
-31,925
-26,478
-45,828
-49,391
-27,513
Net income available to common shareholders
-31,925
-26,478
-45,828
-49,391
-27,513
Basic EPS
-6.60
-12.60
-22.40
-44.80
-36.40
Diluted EPS
-6.60
-12.60
-22.40
-44.80
-36.40
Basic average shares
3,504
2,141
2,059
1,108
760.913
Diluted average shares
3,504
2,141
2,059
1,108
760.913